Trial Outcomes & Findings for My Surgical Success: A Randomized Controlled Pilot Study of a Pre-surgical Psychological Intervention (NCT NCT03076190)

NCT ID: NCT03076190

Last Updated: 2024-04-22

Results Overview

Participants complete a single time point rating for 5 items listed above. Ratings occur on a 0-6 point scale (e.g., 0=completely useless and 6=Very useful). Means and Standard Deviations are reported per the table below.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

131 participants

Primary outcome timeframe

Immediately post-treatment

Results posted on

2024-04-22

Participant Flow

4 participants declined to participate; 127 were randomized

Participant milestones

Participant milestones
Measure
Active Control Group (Health Education)
Prior to surgery: * Demographics survey * Baseline surveys * Participants receive online information regarding nutrition and exercise that are relevant for people recovering from surgery. Participants are encouraged to incorporate healthy lifestyle choices into their daily routines as they recover from surgery. * Follow-up questions about the handouts (detailed above) Post-surgery: * Daily surveys (detailed above) * Follow-up surveys (2, 4, 8, and 12 weeks after surgery)
My Surgical Success Treatment Group
Prior to surgery: * Demographics survey * Baseline surveys * Intervention: * 90-minute psychoeducational My Surgical Success video that emphasizes catastrophizing treatment. * audio file * personalized plan that incorporates the information learned in the video. * Follow-up questions about the video (detailed above) Post-surgery: * Daily surveys (detailed above) * Follow-up surveys (2, 4, 8, and 12 weeks after surgery) Psychoeducational My Surgical Success Video: The 90-minute video includes instruction by Dr. Beth Darnall, PhD, a pain psychologist at the Stanford Pain Management Center. She teaches the viewer about the relationship between stress, pain, and catastrophizing and provides instruction and skills to reduce catastrophizing, decrease stress, and increase relaxation.
Overall Study
STARTED
50
77
Overall Study
COMPLETED
32
36
Overall Study
NOT COMPLETED
18
41

Reasons for withdrawal

Reasons for withdrawal
Measure
Active Control Group (Health Education)
Prior to surgery: * Demographics survey * Baseline surveys * Participants receive online information regarding nutrition and exercise that are relevant for people recovering from surgery. Participants are encouraged to incorporate healthy lifestyle choices into their daily routines as they recover from surgery. * Follow-up questions about the handouts (detailed above) Post-surgery: * Daily surveys (detailed above) * Follow-up surveys (2, 4, 8, and 12 weeks after surgery)
My Surgical Success Treatment Group
Prior to surgery: * Demographics survey * Baseline surveys * Intervention: * 90-minute psychoeducational My Surgical Success video that emphasizes catastrophizing treatment. * audio file * personalized plan that incorporates the information learned in the video. * Follow-up questions about the video (detailed above) Post-surgery: * Daily surveys (detailed above) * Follow-up surveys (2, 4, 8, and 12 weeks after surgery) Psychoeducational My Surgical Success Video: The 90-minute video includes instruction by Dr. Beth Darnall, PhD, a pain psychologist at the Stanford Pain Management Center. She teaches the viewer about the relationship between stress, pain, and catastrophizing and provides instruction and skills to reduce catastrophizing, decrease stress, and increase relaxation.
Overall Study
Lost to Follow-up
9
34
Overall Study
Excluded from Analysis (zero duration ev
9
7

Baseline Characteristics

Overall number of baseline participants represents the number of participants whose ages we had and are not a reflection of how many participants we collected data on. We had missing demographic data on these participants.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Active Control Group (Health Education)
n=32 Participants
Prior to surgery: * Demographics survey * Baseline surveys * Participants receive online information regarding nutrition and exercise that are relevant for people recovering from surgery. Participants are encouraged to incorporate healthy lifestyle choices into their daily routines as they recover from surgery. * Follow-up questions about the handouts (detailed above) Post-surgery: * Daily surveys (detailed above) * Follow-up surveys (2, 4, 8, and 12 weeks after surgery)
My Surgical Success Treatment Group
n=36 Participants
Prior to surgery: * Demographics survey * Baseline surveys * Intervention: * 90-minute psychoeducational My Surgical Success video that emphasizes catastrophizing treatment. * audio file * personalized plan that incorporates the information learned in the video. * Follow-up questions about the video (detailed above) Post-surgery: * Daily surveys (detailed above) * Follow-up surveys (2, 4, 8, and 12 weeks after surgery) Psychoeducational My Surgical Success Video: The 90-minute video includes instruction by Dr. Beth Darnall, PhD, a pain psychologist at the Stanford Pain Management Center. She teaches the viewer about the relationship between stress, pain, and catastrophizing and provides instruction and skills to reduce catastrophizing, decrease stress, and increase relaxation.
Total
n=68 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=31 Participants • Overall number of baseline participants represents the number of participants whose ages we had and are not a reflection of how many participants we collected data on. We had missing demographic data on these participants.
0 Participants
n=30 Participants • Overall number of baseline participants represents the number of participants whose ages we had and are not a reflection of how many participants we collected data on. We had missing demographic data on these participants.
0 Participants
n=61 Participants • Overall number of baseline participants represents the number of participants whose ages we had and are not a reflection of how many participants we collected data on. We had missing demographic data on these participants.
Age, Categorical
Between 18 and 65 years
27 Participants
n=31 Participants • Overall number of baseline participants represents the number of participants whose ages we had and are not a reflection of how many participants we collected data on. We had missing demographic data on these participants.
27 Participants
n=30 Participants • Overall number of baseline participants represents the number of participants whose ages we had and are not a reflection of how many participants we collected data on. We had missing demographic data on these participants.
54 Participants
n=61 Participants • Overall number of baseline participants represents the number of participants whose ages we had and are not a reflection of how many participants we collected data on. We had missing demographic data on these participants.
Age, Categorical
>=65 years
4 Participants
n=31 Participants • Overall number of baseline participants represents the number of participants whose ages we had and are not a reflection of how many participants we collected data on. We had missing demographic data on these participants.
3 Participants
n=30 Participants • Overall number of baseline participants represents the number of participants whose ages we had and are not a reflection of how many participants we collected data on. We had missing demographic data on these participants.
7 Participants
n=61 Participants • Overall number of baseline participants represents the number of participants whose ages we had and are not a reflection of how many participants we collected data on. We had missing demographic data on these participants.
Age, Continuous
51.16 years
STANDARD_DEVIATION 11.45 • n=31 Participants • One participant from the control group and 6 participants from the treatment group had missing demographic data
51.27 years
STANDARD_DEVIATION 11.14 • n=30 Participants • One participant from the control group and 6 participants from the treatment group had missing demographic data
51.21 years
STANDARD_DEVIATION 11.20 • n=61 Participants • One participant from the control group and 6 participants from the treatment group had missing demographic data
Sex: Female, Male
Female
32 Participants
n=32 Participants
36 Participants
n=36 Participants
68 Participants
n=68 Participants
Sex: Female, Male
Male
0 Participants
n=32 Participants
0 Participants
n=36 Participants
0 Participants
n=68 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
n=32 Participants
0 Participants
n=36 Participants
1 Participants
n=68 Participants
Race (NIH/OMB)
Asian
3 Participants
n=32 Participants
10 Participants
n=36 Participants
13 Participants
n=68 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
n=32 Participants
0 Participants
n=36 Participants
1 Participants
n=68 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=32 Participants
0 Participants
n=36 Participants
1 Participants
n=68 Participants
Race (NIH/OMB)
White
23 Participants
n=32 Participants
20 Participants
n=36 Participants
43 Participants
n=68 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=32 Participants
0 Participants
n=36 Participants
0 Participants
n=68 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants
n=32 Participants
6 Participants
n=36 Participants
9 Participants
n=68 Participants
Region of Enrollment
United States
32 participants
n=32 Participants
36 participants
n=36 Participants
68 participants
n=68 Participants

PRIMARY outcome

Timeframe: Immediately post-treatment

Participants complete a single time point rating for 5 items listed above. Ratings occur on a 0-6 point scale (e.g., 0=completely useless and 6=Very useful). Means and Standard Deviations are reported per the table below.

Outcome measures

Outcome measures
Measure
Active Control Group
n=32 Participants
Health Education Active Control Group
My Surgical Success Treatment Group
n=36 Participants
My Surgical Success Intervention Group
Participant Ratings (0-6) for Satisfaction, Usefulness of the Information Presented, Relevance, Ease of Understanding, and Likelihood to Use Skills Learning
Easy to Understand
5.9 units on a scale
Standard Deviation .3
5.9 units on a scale
Standard Deviation .2
Participant Ratings (0-6) for Satisfaction, Usefulness of the Information Presented, Relevance, Ease of Understanding, and Likelihood to Use Skills Learning
Relevant
4.7 units on a scale
Standard Deviation 1.51
5.0 units on a scale
Standard Deviation 1.6
Participant Ratings (0-6) for Satisfaction, Usefulness of the Information Presented, Relevance, Ease of Understanding, and Likelihood to Use Skills Learning
Useful
4.67 units on a scale
Standard Deviation 1.52
5.1 units on a scale
Standard Deviation 1.3
Participant Ratings (0-6) for Satisfaction, Usefulness of the Information Presented, Relevance, Ease of Understanding, and Likelihood to Use Skills Learning
Satisfaction
4.67 units on a scale
Standard Deviation 1.56
5.2 units on a scale
Standard Deviation 1.2
Participant Ratings (0-6) for Satisfaction, Usefulness of the Information Presented, Relevance, Ease of Understanding, and Likelihood to Use Skills Learning
Likely to Use
5.03 units on a scale
Standard Deviation 1.3
5.3 units on a scale
Standard Deviation 1.2

SECONDARY outcome

Timeframe: Before surgery to post-surgically

Population: Before Surgery

Pain Catastrophizing Scale is a validated 13-item measure assessing levels of pain catastrophizing. Scores range from 0-52, with a higher score indicating higher levels of pain catastrophizing. Data below presents total scores on the scale.

Outcome measures

Outcome measures
Measure
Active Control Group
n=32 Participants
Health Education Active Control Group
My Surgical Success Treatment Group
n=36 Participants
My Surgical Success Intervention Group
Group Difference in Within-subject Pain Catastrophizing
8.24 score on a scale
Standard Error 1.19
6.62 score on a scale
Standard Error 1.12

OTHER_PRE_SPECIFIED outcome

Timeframe: Data on opioid use was collected for the 4 month duration of the study

Postsurgical opioid stop date was self-reported by patients. The opioid stop date was collected through the two-, four-, eight-, and 12-week follow-up surveys with the question "On what date did you stop taking your opioid medication?" The number of postsurgical days using opioids was calculated by subtracting the opioid stop date from the surgery date obtained in the medical chart. Statistical analyses present the data in mean number of days to opioid cessation in each group.

Outcome measures

Outcome measures
Measure
Active Control Group
n=32 Participants
Health Education Active Control Group
My Surgical Success Treatment Group
n=36 Participants
My Surgical Success Intervention Group
Group Difference in Time to Opioid Cessation
21.83 Days to opioid cessation
Standard Error 4.11
11.19 Days to opioid cessation
Standard Error 2.21

OTHER_PRE_SPECIFIED outcome

Timeframe: From baseline to post-surgery (up to 4 months duration of the study)

PROMIS scores for physical function and pain interference will be reported post-surgically. All PROMIS assessments were converted from raw scores to t-scores (Mean= 50, SD=10). Higher scores on PROMIS pain interference signify greater severity of pain interfering with patient's functioning. However, higher scores on Physical function reflects a greater level of physical functioning. The investigators will conduct within subject analyses and will report pre-post treatment changes.

Outcome measures

Outcome measures
Measure
Active Control Group
n=32 Participants
Health Education Active Control Group
My Surgical Success Treatment Group
n=36 Participants
My Surgical Success Intervention Group
Group Difference in Post-surgical PROMIS Physical Function and PROMIS Pain Interference
Pain Interference
4.31 score on a scale
Standard Deviation 9.65
6.77 score on a scale
Standard Deviation 9.31
Group Difference in Post-surgical PROMIS Physical Function and PROMIS Pain Interference
Physical Health
2.56 score on a scale
Standard Deviation 6.41
0.72 score on a scale
Standard Deviation 6.15

OTHER_PRE_SPECIFIED outcome

Timeframe: Baseline

The investigators will report the baseline psychosocial scores (PROMIS measures) for patients who report high satisfaction with the My Surgical Success treatment. Pain Intensity Scale ranges from 0 (no Pain) to 10 (the worst pain imaginable), with higher scores indicating worse pain. Total scores range from 0-10. Pain Catastrophizing Scale is a 13-item measure assessing levels of pain catastrophizing. Scores range from 0-52, with a higher score indicating higher levels of pain catastrophizing. All PROMIS assessments were converted from raw scores to t-scores (M= 50, SD=10). There are no minimum and maximum values as these are standardized scores. PROMIS Pain Intensity, Pain Interference, Physical Function, Depression, Anxiety, were administered at baseline. Higher scores on PROMIS depression, anxiety, pain interference, and pain intensity signify greater severity of these symptoms. However, higher scores on Physical Function reflects a greater level of physical functioning.

Outcome measures

Outcome measures
Measure
Active Control Group
n=36 Participants
Health Education Active Control Group
My Surgical Success Treatment Group
My Surgical Success Intervention Group
Characterize Responders to My Surgical Success (Demographics and Psychological Correlates)
Pain Intensity
1.47 score on a scale
Standard Deviation 1.12
Characterize Responders to My Surgical Success (Demographics and Psychological Correlates)
Pain Catastrophizing
7.33 score on a scale
Standard Deviation 1.3
Characterize Responders to My Surgical Success (Demographics and Psychological Correlates)
PROMIS physical functioning
37.52 score on a scale
Standard Deviation 5.42
Characterize Responders to My Surgical Success (Demographics and Psychological Correlates)
PROMIS Pain Interference
47.49 score on a scale
Standard Deviation 1.59
Characterize Responders to My Surgical Success (Demographics and Psychological Correlates)
PROMIS Depression
47.15 score on a scale
Standard Deviation 1.29
Characterize Responders to My Surgical Success (Demographics and Psychological Correlates)
PROMIS Anxiety
54.49 score on a scale
Standard Deviation 1.48

Adverse Events

Active Control Group (Health Education)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

My Surgical Success Treatment Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Beth Darnall

Stanford University

Phone: 6507365494

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place